CrossrefInfokarte
Correspondence on ‘Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials’ by Annfeldt et al
Annals of the Rheumatic Diseases · 2026-11 · 85 (11) · e121-e122
DOI: 10.1016/j.ard.2026.06.035 ↗Abstract
Kein Abstract verfügbar.
EUVIMED